BioCorRx Inc. is a healthcare solutions development company. It treats alcoholism and opioid addictions. The company's addiction treatment program consists of BioCorRx(R) Recovery Program. BioCorRx Inc. is headquartered in Santa Ana, California.
| Revenue (Most Recent Fiscal Year) | $0.01M |
| Net Income (Most Recent Fiscal Year) | $-5.11M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -450.00% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -96.39% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.10 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.09 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 3.40 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.93 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.11 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.49 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.32 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 23.69M |
| Free Float | 18.62M |
| Market Capitalization | $8.23M |
| Average Volume (Last 20 Days) | 588.50 |
| Beta (Past 60 Months) | 0.16 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 21.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |